LVP — Little Vampire Girl
Tropicanna Cookies × Project 4516. Published profile.
View profile →
Each MedCana strain ships with its own dossier — cannabinoid and terpene panels, batch and lot identifiers, ICA resolution number, and the lab that performed the analysis.
LVP and BWI are our publicly published profiles. Other strains — including additional THC-dominant hybrids, CBD-rich cultivars, and balanced 1:1 profiles — are available to qualified buyers under NDA.
Tropicanna Cookies × Project 4516. Published profile.
View profile →Chocolope Kush × Red Beard. Published profile.
View profile →Balanced THC/CBD profile under development for medical applications.
High-CBD cultivar for extract production and pediatric applications.
There is a reason MedCana's flower keeps testing the way it does. The farm sits at 2,120 m (6,960 ft) in the Antioquia highlands, on the equator. At that altitude the ultraviolet light is intense and unfiltered — and UV stress is one of the strongest natural triggers a cannabis plant has for laying down trichomes and the terpenes and cannabinoids they hold. The mountain wind, the wide day-to-night temperature swing, the stable equatorial light cycle: every one of these is a gentle, constant stressor that the plant answers by producing more resin.
This is terroir, in the sense a vineyard would understand it — and it is not a one-off. Across six consecutive crops, the same site has produced flower with consistently dense trichome coverage and consistently high terpene expression. Consistency is the hard part. Anyone can get one good harvest; reproducing it cycle after cycle is what separates a place from a fluke.
Industry reference points. Most commercial cannabis tests at 1–2% total terpenes; 2–4% is considered high quality and 4–6% premium grade, with levels above 4% described across the industry as rare. Both MedCana cultivars land at the top of that range.
β-Caryophyllene 1.25% · Limonene 1.16% · Humulene 0.39% · Cis-Nerolidol 0.22% · Fenchone 0.17% — total 3.85% dry weight.
Limonene 1.11% · β-Caryophyllene 1.00% · β-Myrcene 0.64% · Humulene 0.44% · Fenchone 0.19% — total 4.11% dry weight.
Put plainly: MedCana is producing premium-tier terpene flower from a greenhouse, at a cost structure most growers can only reach indoors — and reaching it consistently, crop after crop, because the conditions that drive it are the climate itself, not a setting on a panel. That is difficult to replicate anywhere else in the world, because it is not a technique. It is a place.
The clinical applications below drive demand for the kind of standardized, traceable, audit-ready product MedCana produces. We don't make medical claims about our genetics — we make sure they meet the spec a clinical supply chain requires.
MedCana does not market its products as treatments for any specific condition. The categories above describe areas where pharmaceutical-grade cannabis is being investigated and prescribed by licensed clinicians.
Eko2o Engineering S.A.S. is MedCana's agrotech company. It engineers the greenhouses, irrigation, and environmental-control systems that run our own farms — and installs the same systems for outside cannabis and agricultural operators.
Passive-climate greenhouse structures engineered for the equatorial highland — no industrial heating or supplemental lighting required.
Drip irrigation, fertigation, and water-management systems designed around spring-fed supply and precise delivery.
Sensor networks and climate-control loops that track and regulate the growing environment, designed to integrate with the planned Tokan ERP.
Qualified buyers — distributors, importers, pharmacies, extract processors — can request samples and full certificates of analysis for any strain in the catalogue.
Hospitals, universities, and research groups: we supply standardized cannabinoid and terpene-profiled material for clinical and pharmacological research under appropriate regulatory frameworks.